ijms-logo

Journal Browser

Journal Browser

Tissue Engineering and Cell Therapy

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Biochemistry".

Deadline for manuscript submissions: closed (31 October 2022) | Viewed by 24526

Special Issue Editor


E-Mail Website
Guest Editor
1. Department of Surgery, Faculty of Medicine, Université Laval, Québec, QC G1V 0A6, Canada
2. Regenerative Medicine Division, CHU de Québec—Université Laval Research Centre, Québec, QC G1J 1Z4, Canada
3. Centre de Recherche en Organogénèse Expérimentale de l’Université Laval/LOEX, Hôpital Enfant-Jésus, 1401 18e Rue, Québec, QC G1V 0A6, Canada
Interests: epithelial stem cells; tissue engineering; regenerative medicine; cell therapy; skin
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The clinical need to replace wounded, damaged or pathological tissues and organs has fostered the development of tissue engineering and cellular therapies. Innovative research on biomaterials, extracellular matrix and cells has resulted in tissue substitutes or cell products that are designed to improve, repair or replace several tissues and organs. This Special Issue will gather studies on the recent advances in this area. It will feature research that reports such progress, including fundamental studies on reconstructed tissues in vitro or translational studies and pre-clinical testing in vivo.

Prof. Dr. Lucie Germain
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • biomaterials and cell sources for tissue engineering and cell therapy
  • tissue engineering of substitutes in vitro
  • functional testing of tissues reconstructed in vitro
  • extracellular matrix
  • mechanical characteristics
  • biological and histological characterization
  • translational research

Published Papers (10 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

22 pages, 5169 KiB  
Article
Culture Conditions for Human Induced Pluripotent Stem Cell-Derived Schwann Cells: A Two-Centre Study
by Zhong Huang, Rebecca Powell, Svenja Kankowski, James B. Phillips and Kirsten Haastert-Talini
Int. J. Mol. Sci. 2023, 24(6), 5366; https://doi.org/10.3390/ijms24065366 - 10 Mar 2023
Cited by 1 | Viewed by 2214
Abstract
Adult human Schwann cells represent a relevant tool for studying peripheral neuropathies and developing regenerative therapies to treat nerve damage. Primary adult human Schwann cells are, however, difficult to obtain and challenging to propagate in culture. One potential solution is to generate Schwann [...] Read more.
Adult human Schwann cells represent a relevant tool for studying peripheral neuropathies and developing regenerative therapies to treat nerve damage. Primary adult human Schwann cells are, however, difficult to obtain and challenging to propagate in culture. One potential solution is to generate Schwann cells from human induced pluripotent stem cells (hiPSCs). Previously published protocols, however, in our hands did not deliver sufficient viable cell numbers of hiPSC-derived Schwann cells (hiPSC-SCs). We present here, two modified protocols from two collaborating laboratories that overcome these challenges. With this, we also identified the relevant parameters to be specifically considered in any proposed differentiation protocol. Furthermore, we are, to our knowledge, the first to directly compare hiPSC-SCs to primary adult human Schwann cells using immunocytochemistry and RT-qPCR. We conclude the type of coating to be important during the differentiation process from Schwann cell precursor cells or immature Schwann cells to definitive Schwann cells, as well as the amounts of glucose in the specific differentiation medium to be crucial for increasing its efficiency and the final yield of viable hiPSC-SCs. Our hiPSC-SCs further displayed high similarity to primary adult human Schwann cells. Full article
(This article belongs to the Special Issue Tissue Engineering and Cell Therapy)
Show Figures

Graphical abstract

19 pages, 3269 KiB  
Article
A Newly Developed Chemically Defined Serum-Free Medium Suitable for Human Primary Keratinocyte Culture and Tissue Engineering Applications
by Sergio Cortez Ghio, Martin A. Barbier, Emilie J. Doucet, Imad Debbah, Meryem Safoine, Gaëtan Le-Bel, Andréanne Cartier, Emilie Jolibois, Amélie Morissette, Danielle Larouche, Julie Fradette, Sylvain L. Guérin, Alain Garnier and Lucie Germain
Int. J. Mol. Sci. 2023, 24(3), 1821; https://doi.org/10.3390/ijms24031821 - 17 Jan 2023
Cited by 3 | Viewed by 2057
Abstract
In our experience, keratinocytes cultured in feeder-free conditions and in commercially available defined and serum-free media cannot be as efficiently massively expanded as their counterparts grown in conventional bovine serum-containing medium, nor can they properly form a stratified epidermis in a skin substitute [...] Read more.
In our experience, keratinocytes cultured in feeder-free conditions and in commercially available defined and serum-free media cannot be as efficiently massively expanded as their counterparts grown in conventional bovine serum-containing medium, nor can they properly form a stratified epidermis in a skin substitute model. We thus tested a new chemically defined serum-free medium, which we developed for massive human primary keratinocyte expansion and skin substitute production. Our medium, named Surge Serum-Free Medium (Surge SFM), was developed to be used alongside a feeder layer. It supports the growth of keratinocytes freshly isolated from a skin biopsy and cryopreserved primary keratinocytes in cultured monolayers over multiple passages. We also show that keratin-19-positive epithelial stem cells are retained through serial passaging in Surge SFM cultures. Transcriptomic analyses suggest that gene expression is similar between keratinocytes cultured with either Surge SFM or the conventional serum-containing medium. Additionally, Surge SFM can be used to produce bilayered self-assembled skin substitutes histologically similar to those produced using serum-containing medium. Furthermore, these substitutes were grafted onto athymic mice and persisted for up to six months. In conclusion, our new chemically defined serum-free keratinocyte culture medium shows great promise for basic research and clinical applications. Full article
(This article belongs to the Special Issue Tissue Engineering and Cell Therapy)
Show Figures

Figure 1

14 pages, 3347 KiB  
Article
Exploring the Concept of In Vivo Guided Tissue Engineering by a Single-Stage Surgical Procedure in a Rodent Model
by Clara Ibel Chamorro, Said Zeiai, Nikolai Juul, Oliver Willacy, Jinxing Huo, Jöns Hilborn and Magdalena Fossum
Int. J. Mol. Sci. 2022, 23(20), 12703; https://doi.org/10.3390/ijms232012703 - 21 Oct 2022
Cited by 2 | Viewed by 1511
Abstract
In severe malformations with a lack of native tissues, treatment options are limited. We aimed at expanding tissue in vivo using the body as a bioreactor and developing a sustainable single-staged procedure for autologous tissue reconstruction in malformation surgery. Autologous micro-epithelium from skin [...] Read more.
In severe malformations with a lack of native tissues, treatment options are limited. We aimed at expanding tissue in vivo using the body as a bioreactor and developing a sustainable single-staged procedure for autologous tissue reconstruction in malformation surgery. Autologous micro-epithelium from skin was integrated with plastically compressed collagen and a degradable knitted fabric mesh. Sixty-three scaffolds were implanted in nine rats for histological and mechanical analyses, up to 4 weeks after transplantation. Tissue integration, cell expansion, proliferation, inflammation, strength, and elasticity were evaluated over time in vivo and validated in vitro in a bladder wound healing model. After 5 days in vivo, we observed keratinocyte proliferation on top of the transplant, remodeling of the collagen, and neovascularization within the transplant. At 4 weeks, all transplants were fully integrated with the surrounding tissue. Tensile strength and elasticity were retained during the whole study period. In the in vitro models, a multilayered epithelium covered the defect after 4 weeks. Autologous micro-epithelial transplants allowed for cell expansion and reorganization in vivo without conventional pre-operative in vitro cell propagation. The method was easy to perform and did not require handling outside the operating theater. Full article
(This article belongs to the Special Issue Tissue Engineering and Cell Therapy)
Show Figures

Figure 1

17 pages, 1771 KiB  
Article
Evaluation of a Serum-Free Medium for Human Epithelial and Stromal Cell Culture
by Christophe Caneparo, Stéphane Chabaud, Julie Fradette and Stéphane Bolduc
Int. J. Mol. Sci. 2022, 23(17), 10035; https://doi.org/10.3390/ijms231710035 - 02 Sep 2022
Cited by 5 | Viewed by 2007
Abstract
Over the past decade, growing demand from many domains (research, cosmetics, pharmaceutical industries, etc.) has given rise to significant expansion of the number of in vitro cell cultures. Despite the widespread use of fetal bovine serum, many issues remain. Among them, the whole [...] Read more.
Over the past decade, growing demand from many domains (research, cosmetics, pharmaceutical industries, etc.) has given rise to significant expansion of the number of in vitro cell cultures. Despite the widespread use of fetal bovine serum, many issues remain. Among them, the whole constitution of most serums remains unknown and is subject to significant variations. Furthermore, the presence of potential contamination and xenogeny elements is challenging for clinical applications, while limited production is an obstacle to the growing demand. To circumvent these issues, a Serum-Free Medium (SFM) has been developed to culture dermal and vesical fibroblasts and their corresponding epithelial cells, namely, keratinocytes and urothelial cells. To assess the impact of SFM on these cells, proliferation, clonogenic and metabolic assays have been compared over three passages to conditions associated with the use of a classic Fetal Bovine Serum-Containing Medium (FBSCM). The results showed that the SFM enabled fibroblast and epithelial cell proliferation while maintaining a morphology, cell size and metabolism similar to those of FBSCM. SFM has repeatedly been found to be better suited for epithelial cell proliferation and clonogenicity. Fibroblasts and epithelial cells also showed more significant mitochondrial metabolism in the SFM compared to the FBSCM condition. However, the SFM may need further optimization to improve fibroblast proliferation. Full article
(This article belongs to the Special Issue Tissue Engineering and Cell Therapy)
Show Figures

Figure 1

15 pages, 3468 KiB  
Article
Biofabrication of Sodium Alginate Hydrogel Scaffolds for Heart Valve Tissue Engineering
by Yannick Rioux, Julie Fradette, Yvan Maciel, André Bégin-Drolet and Jean Ruel
Int. J. Mol. Sci. 2022, 23(15), 8567; https://doi.org/10.3390/ijms23158567 - 02 Aug 2022
Cited by 15 | Viewed by 2832
Abstract
Every year, thousands of aortic valve replacements must take place due to valve diseases. Tissue-engineered heart valves represent promising valve substitutes with remodeling, regeneration, and growth capabilities. However, the accurate reproduction of the complex three-dimensional (3D) anatomy of the aortic valve remains a [...] Read more.
Every year, thousands of aortic valve replacements must take place due to valve diseases. Tissue-engineered heart valves represent promising valve substitutes with remodeling, regeneration, and growth capabilities. However, the accurate reproduction of the complex three-dimensional (3D) anatomy of the aortic valve remains a challenge for current biofabrication methods. We present a novel technique for rapid fabrication of native-like tricuspid aortic valve scaffolds made of an alginate-based hydrogel. Using this technique, a sodium alginate hydrogel formulation is injected into a mold produced using a custom-made sugar glass 3D printer. The mold is then dissolved using a custom-made dissolving module, revealing the aortic valve scaffold. To assess the reproducibility of the technique, three scaffolds were thoroughly compared. CT (computed tomography) scans showed that the scaffolds respect the complex native geometry with minimal variations. The scaffolds were then tested in a cardiac bioreactor specially designed to reproduce physiological flow and pressure (aortic and ventricular) conditions. The flow and pressure profiles were similar to the physiological ones for the three valve scaffolds, with small variabilities. These early results establish the functional repeatability of this new biofabrication method and suggest its application for rapid fabrication of ready-to-use cell-seeded sodium alginate scaffolds for heart valve tissue engineering. Full article
(This article belongs to the Special Issue Tissue Engineering and Cell Therapy)
Show Figures

Figure 1

Review

Jump to: Research

34 pages, 2106 KiB  
Review
Tissue Engineering for Gastrointestinal and Genitourinary Tracts
by Elissa Elia, David Brownell, Stéphane Chabaud and Stéphane Bolduc
Int. J. Mol. Sci. 2023, 24(1), 9; https://doi.org/10.3390/ijms24010009 - 20 Dec 2022
Cited by 3 | Viewed by 2173
Abstract
The gastrointestinal and genitourinary tracts share several similarities. Primarily, these tissues are composed of hollow structures lined by an epithelium through which materials need to flow with the help of peristalsis brought by muscle contraction. In the case of the gastrointestinal tract, solid [...] Read more.
The gastrointestinal and genitourinary tracts share several similarities. Primarily, these tissues are composed of hollow structures lined by an epithelium through which materials need to flow with the help of peristalsis brought by muscle contraction. In the case of the gastrointestinal tract, solid or liquid food must circulate to be digested and absorbed and the waste products eliminated. In the case of the urinary tract, the urine produced by the kidneys must flow to the bladder, where it is stored until its elimination from the body. Finally, in the case of the vagina, it must allow the evacuation of blood during menstruation, accommodate the male sexual organ during coitus, and is the natural way to birth a child. The present review describes the anatomy, pathologies, and treatments of such organs, emphasizing tissue engineering strategies. Full article
(This article belongs to the Special Issue Tissue Engineering and Cell Therapy)
Show Figures

Figure 1

17 pages, 675 KiB  
Review
Sources, Selection, and Microenvironmental Preconditioning of Cells for Urethral Tissue Engineering
by Zongzhe Xuan, Vladimir Zachar and Cristian Pablo Pennisi
Int. J. Mol. Sci. 2022, 23(22), 14074; https://doi.org/10.3390/ijms232214074 - 15 Nov 2022
Cited by 7 | Viewed by 1916
Abstract
Urethral stricture is a common urinary tract disorder in men that can be caused by iatrogenic causes, trauma, inflammation, or infection and often requires reconstructive surgery. The current therapeutic approach for complex urethral strictures usually involves reconstruction with autologous tissue from the oral [...] Read more.
Urethral stricture is a common urinary tract disorder in men that can be caused by iatrogenic causes, trauma, inflammation, or infection and often requires reconstructive surgery. The current therapeutic approach for complex urethral strictures usually involves reconstruction with autologous tissue from the oral mucosa. With the goal of overcoming the lack of sufficient autologous tissue and donor site morbidity, research over the past two decades has focused on cell-based tissue-engineered substitutes. While the main focus has been on autologous cells from the penile tissue, bladder, and oral cavity, stem cells from sources such as adipose tissue and urine are competing candidates for future urethral regeneration due to their ease of collection, high proliferative capacity, maturation potential, and paracrine function. This review addresses the sources, advantages, and limitations of cells for tissue engineering in the urethra and discusses recent approaches to improve cell survival, growth, and differentiation by mimicking the mechanical and biophysical properties of the extracellular environment. Full article
(This article belongs to the Special Issue Tissue Engineering and Cell Therapy)
Show Figures

Graphical abstract

37 pages, 6161 KiB  
Review
Prospects and Challenges of Electrospun Cell and Drug Delivery Vehicles to Correct Urethral Stricture
by Saeed Farzamfar, Elissa Elia, Stéphane Chabaud, Mohammad Naji and Stéphane Bolduc
Int. J. Mol. Sci. 2022, 23(18), 10519; https://doi.org/10.3390/ijms231810519 - 10 Sep 2022
Cited by 9 | Viewed by 3426
Abstract
Current therapeutic modalities to treat urethral strictures are associated with several challenges and shortcomings. Therefore, significant strides have been made to develop strategies with minimal side effects and the highest therapeutic potential. In this framework, electrospun scaffolds incorporated with various cells or bioactive [...] Read more.
Current therapeutic modalities to treat urethral strictures are associated with several challenges and shortcomings. Therefore, significant strides have been made to develop strategies with minimal side effects and the highest therapeutic potential. In this framework, electrospun scaffolds incorporated with various cells or bioactive agents have provided promising vistas to repair urethral defects. Due to the biomimetic nature of these constructs, they can efficiently mimic the native cells’ niches and provide essential microenvironmental cues for the safe transplantation of multiple cell types. Furthermore, these scaffolds are versatile platforms for delivering various drug molecules, growth factors, and nucleic acids. This review discusses the recent progress, applications, and challenges of electrospun scaffolds to deliver cells or bioactive agents during the urethral defect repair process. First, the current status of electrospinning in urethral tissue engineering is presented. Then, the principles of electrospinning in drug and cell delivery applications are reviewed. Finally, the recent preclinical studies are summarized and the current challenges are discussed. Full article
(This article belongs to the Special Issue Tissue Engineering and Cell Therapy)
Show Figures

Figure 1

25 pages, 3053 KiB  
Review
Vascularization in Bioartificial Parenchymal Tissue: Bioink and Bioprinting Strategies
by Gabriel Alexander Salg, Andreas Blaeser, Jamina Sofie Gerhardus, Thilo Hackert and Hannes Goetz Kenngott
Int. J. Mol. Sci. 2022, 23(15), 8589; https://doi.org/10.3390/ijms23158589 - 02 Aug 2022
Cited by 11 | Viewed by 2982
Abstract
Among advanced therapy medicinal products, tissue-engineered products have the potential to address the current critical shortage of donor organs and provide future alternative options in organ replacement therapy. The clinically available tissue-engineered products comprise bradytrophic tissue such as skin, cornea, and cartilage. A [...] Read more.
Among advanced therapy medicinal products, tissue-engineered products have the potential to address the current critical shortage of donor organs and provide future alternative options in organ replacement therapy. The clinically available tissue-engineered products comprise bradytrophic tissue such as skin, cornea, and cartilage. A sufficient macro- and microvascular network to support the viability and function of effector cells has been identified as one of the main challenges in developing bioartificial parenchymal tissue. Three-dimensional bioprinting is an emerging technology that might overcome this challenge by precise spatial bioink deposition for the generation of a predefined architecture. Bioinks are printing substrates that may contain cells, matrix compounds, and signaling molecules within support materials such as hydrogels. Bioinks can provide cues to promote vascularization, including proangiogenic signaling molecules and cocultured cells. Both of these strategies are reported to enhance vascularization. We review pre-, intra-, and postprinting strategies such as bioink composition, bioprinting platforms, and material deposition strategies for building vascularized tissue. In addition, bioconvergence approaches such as computer simulation and artificial intelligence can support current experimental designs. Imaging-derived vascular trees can serve as blueprints. While acknowledging that a lack of structured evidence inhibits further meta-analysis, this review discusses an end-to-end process for the fabrication of vascularized, parenchymal tissue. Full article
(This article belongs to the Special Issue Tissue Engineering and Cell Therapy)
Show Figures

Figure 1

18 pages, 2016 KiB  
Review
A Systematic Review of Keratinocyte Secretions: A Regenerative Perspective
by Ahmed T. El-Serafi, Ibrahim El-Serafi, Ingrid Steinvall, Folke Sjöberg and Moustafa Elmasry
Int. J. Mol. Sci. 2022, 23(14), 7934; https://doi.org/10.3390/ijms23147934 - 19 Jul 2022
Cited by 11 | Viewed by 2342
Abstract
Cell regenerative therapy is a modern solution for difficult-to-heal wounds. Keratinocytes, the most common cell type in the skin, are difficult to obtain without the creation of another wound. Stem cell differentiation towards keratinocytes is a challenging process, and it is difficult to [...] Read more.
Cell regenerative therapy is a modern solution for difficult-to-heal wounds. Keratinocytes, the most common cell type in the skin, are difficult to obtain without the creation of another wound. Stem cell differentiation towards keratinocytes is a challenging process, and it is difficult to reproduce in chemically defined media. Nevertheless, a co-culture of keratinocytes with stem cells usually achieves efficient differentiation. This systematic review aims to identify the secretions of normal human keratinocytes reported in the literature and correlate them with the differentiation process. An online search revealed 338 references, of which 100 met the selection criteria. A total of 80 different keratinocyte secretions were reported, which can be grouped mainly into cytokines, growth factors, and antimicrobial peptides. The growth-factor group mostly affects stem cell differentiation into keratinocytes, especially epidermal growth factor and members of the transforming growth factor family. Nevertheless, the reported secretions reflected the nature of the involved studies, as most of them focused on keratinocyte interaction with inflammation. This review highlights the secretory function of keratinocytes, as well as the need for intense investigation to characterize these secretions and evaluate their regenerative capacities. Full article
(This article belongs to the Special Issue Tissue Engineering and Cell Therapy)
Show Figures

Figure 1

Back to TopTop